JP2023547062A5 - - Google Patents

Info

Publication number
JP2023547062A5
JP2023547062A5 JP2023523094A JP2023523094A JP2023547062A5 JP 2023547062 A5 JP2023547062 A5 JP 2023547062A5 JP 2023523094 A JP2023523094 A JP 2023523094A JP 2023523094 A JP2023523094 A JP 2023523094A JP 2023547062 A5 JP2023547062 A5 JP 2023547062A5
Authority
JP
Japan
Prior art keywords
softgel capsule
modified release
capsule according
composition
controlled release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023523094A
Other languages
English (en)
Japanese (ja)
Other versions
JP7897229B2 (ja
JP2023547062A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/071900 external-priority patent/WO2022082222A1/en
Publication of JP2023547062A publication Critical patent/JP2023547062A/ja
Publication of JP2023547062A5 publication Critical patent/JP2023547062A5/ja
Application granted granted Critical
Publication of JP7897229B2 publication Critical patent/JP7897229B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023523094A 2020-10-16 2021-10-15 改変放出ソフトゲルカプセル Active JP7897229B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063092762P 2020-10-16 2020-10-16
US63/092,762 2020-10-16
PCT/US2021/071900 WO2022082222A1 (en) 2020-10-16 2021-10-15 Modified release softgel capsules

Publications (3)

Publication Number Publication Date
JP2023547062A JP2023547062A (ja) 2023-11-09
JP2023547062A5 true JP2023547062A5 (cg-RX-API-DMAC10.html) 2024-10-22
JP7897229B2 JP7897229B2 (ja) 2026-07-29

Family

ID=81208677

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023523094A Active JP7897229B2 (ja) 2020-10-16 2021-10-15 改変放出ソフトゲルカプセル

Country Status (13)

Country Link
US (1) US20230390210A1 (cg-RX-API-DMAC10.html)
EP (1) EP4228597A4 (cg-RX-API-DMAC10.html)
JP (1) JP7897229B2 (cg-RX-API-DMAC10.html)
KR (1) KR20230088388A (cg-RX-API-DMAC10.html)
CN (1) CN116322655A (cg-RX-API-DMAC10.html)
AR (1) AR123805A1 (cg-RX-API-DMAC10.html)
AU (1) AU2021362248A1 (cg-RX-API-DMAC10.html)
BR (1) BR112023006154A2 (cg-RX-API-DMAC10.html)
CA (1) CA3194160A1 (cg-RX-API-DMAC10.html)
CO (1) CO2023005753A2 (cg-RX-API-DMAC10.html)
IL (1) IL301715A (cg-RX-API-DMAC10.html)
MX (1) MX2023004418A (cg-RX-API-DMAC10.html)
WO (1) WO2022082222A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117705978A (zh) * 2023-12-14 2024-03-15 河南泰丰生物科技有限公司 一种四烯甲奈醌软胶囊溶出曲线的测定方法
CN122458978A (zh) * 2023-12-22 2026-07-24 花王株式会社 胶囊剂

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61151127A (ja) * 1984-12-25 1986-07-09 Meiji Milk Prod Co Ltd ビフイズス菌含有ソフトカプセルの製造方法
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US7842307B2 (en) * 2001-08-06 2010-11-30 Purdue Pharma L.P. Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
DE60238269D1 (de) * 2001-11-22 2010-12-23 Morishita Jintan Co Nicht-gelatinöse Kapseln
KR100575199B1 (ko) * 2003-01-24 2006-05-02 알앤피코리아주식회사 연질 캡슐의 블루밍 방지를 위한 가소제 조성물 및 이를함유한 피막
IT1401313B1 (it) * 2010-08-05 2013-07-18 Perfetti Van Melle Spa Caramelle gelatinose con ripieno fluido e metodo di ottenimento
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
GB201304662D0 (en) * 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
WO2015200149A1 (en) 2014-06-23 2015-12-30 Banner Life Sciences Llc All natural enteric soft capsules comprising active ingredients
US9877971B2 (en) * 2015-06-15 2018-01-30 Banner Life Sciences Llc Soft lozenges comprising corticosteroids
US20170119680A1 (en) * 2015-10-30 2017-05-04 R.P. Scherer Technologies, Llc Extended release film-coated capsules
AU2019362883B2 (en) * 2018-10-16 2025-07-31 Bayer Healthcare Llc Softgels with solid or gel-like polymeric fill matrix
EP4674410A3 (en) * 2019-10-28 2026-03-18 R.P. Scherer Technologies, LLC Delayed release softgel capsules in higher ph environment

Similar Documents

Publication Publication Date Title
JP2022535539A5 (cg-RX-API-DMAC10.html)
US10874619B2 (en) Acid resistant capsules
ES2302926T5 (es) Cápsula blanda masticable
JP5192816B2 (ja) 非ゼラチン軟質カプセルシステム
EP3178473B1 (en) Acid resistant capsule shell and its preparation process
JP2006505542A (ja) 腸溶性調製物
JP7830458B2 (ja) 遅延放出ソフトゲルカプセル
JP2004502723A (ja) 徐放性および遅延性吸収の経口医薬組成物
JP2005506998A5 (cg-RX-API-DMAC10.html)
TW201422254A (zh) 用於速釋及延釋的組成物
US20170258869A1 (en) Pharmaceutical Compositions for Colon-Specific Delivery
US20190000768A1 (en) Enteric capsule
JP7628537B2 (ja) より高いph環境における遅延放出ソフトゲルカプセル
IL276943B1 (en) Enteric softgel capsules
TW202233164A (zh) 緩釋軟膠囊
JP2023548711A5 (cg-RX-API-DMAC10.html)
JP2022525482A (ja) 胃内滞留剤形用のコーティング
JP2022525926A (ja) 胃内滞留剤形用のカプセル及びカプセルコーティング
JP2023532180A5 (cg-RX-API-DMAC10.html)
CN114845700A (zh) Otf的可溶性背衬层
CN102753146B (zh) 可经口施用的表皮生长因子药物小丸
JP2025508321A5 (cg-RX-API-DMAC10.html)
JP7719609B2 (ja) 腸溶性硬質カプセル
US20090148480A1 (en) Sustained release preparation
JP7325753B2 (ja) 潰瘍性大腸炎治療カプセル剤